{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:27:21Z","timestamp":1787236041065,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T00:00:00Z","timestamp":1751760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14563-5","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T13:05:02Z","timestamp":1751807102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recognition of cancer chemotherapy adverse effect by patients: a cross-sectional study from Palestine"],"prefix":"10.1186","volume":"25","author":[{"given":"Ayah","family":"Maqdasawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rawan","family":"Ghanayiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan","family":"Mosleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramzi","family":"Shawahna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,6]]},"reference":[{"issue":"1","key":"14563_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"14563_CR2","unstructured":"Global cancer burden growing. amidst mounting need for services. https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services."},{"key":"14563_CR3","doi-asserted-by":"crossref","unstructured":"Siddiqui AA, Amin J, Alshammary F, Afroze E, Shaikh S, Rathore HA, Khan R. Burden of Cancer in the Arab World. In: Handbook of Healthcare in the Arab World. edn. Edited by Laher I. Cham: Springer International Publishing; 2021:495\u2013519.","DOI":"10.1007\/978-3-030-36811-1_182"},{"issue":"8","key":"14563_CR4","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1007\/s00432-022-04430-2","volume":"149","author":"HS Salem","year":"2023","unstructured":"Salem HS. Cancer status in the occupied Palestinian territories: types; incidence; mortality; sex, age, and geography distribution; and possible causes. J Cancer Res Clin Oncol. 2023;149(8):5139\u201363.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"14563_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","volume":"71","author":"N Behranvand","year":"2022","unstructured":"Behranvand N, Nasri F, Zolfaghari Emameh R, Khani P, Hosseini A, Garssen J, Falak R. Chemotherapy: a double-edged sword in cancer treatment. Cancer Immunol Immunother. 2022;71(3):507\u201326.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"14563_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/FTD.0000000000000701","volume":"42","author":"CE Knezevic","year":"2020","unstructured":"Knezevic CE, Clarke W. Cancer chemotherapy: the case for therapeutic drug monitoring. Ther Drug Monit. 2020;42(1):6\u201319.","journal-title":"Ther Drug Monit"},{"issue":"12","key":"14563_CR7","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/ijd.16361","volume":"61","author":"ED Saadet","year":"2022","unstructured":"Saadet ED, Tek I. Evaluation of chemotherapy-induced cutaneous side effects in cancer patients. Int J Dermatol. 2022;61(12):1519\u201326.","journal-title":"Int J Dermatol"},{"issue":"2","key":"14563_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s40264-021-01132-5","volume":"45","author":"J Tamargo","year":"2022","unstructured":"Tamargo J, Caballero R, Delp\u00f3n E. Cancer chemotherapy-induced sinus bradycardia: a narrative review of a forgotten adverse effect of cardiotoxicity. Drug Saf. 2022;45(2):101\u201326.","journal-title":"Drug Saf"},{"issue":"11","key":"14563_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1080\/14740338.2022.2151584","volume":"21","author":"P Di Nardo","year":"2022","unstructured":"Di Nardo P, Lisanti C, Garutti M, Buriolla S, Alberti M, Mazzeo R, Puglisi F. Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. Expert Opin Drug Saf. 2022;21(11):1341\u201355.","journal-title":"Expert Opin Drug Saf"},{"key":"14563_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/nu15122666","author":"Y Ferro","year":"2023","unstructured":"Ferro Y, Maurotti S, Tarsitano MG, Lodari O, Pujia R, Mazza E, Lascala L, Russo R, Pujia A, Montalcini T. Therapeutic fasting in reducing chemotherapy side effects in cancer patients: a systematic review and meta-analysis. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15122666.","journal-title":"Nutrients"},{"issue":"4","key":"14563_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1139\/cjpp-2021-0622","volume":"100","author":"S De Francia","year":"2022","unstructured":"De Francia S, Mancardi D, Berchialla P, Armando T, Storto S, Allegra S, Soave G, Racca S, Chiara F, Carnovale J, et al. Gender-specific side effects of chemotherapy in pancreatic cancer patients. Can J Physiol Pharmacol. 2022;100(4):371\u20137.","journal-title":"Can J Physiol Pharmacol"},{"key":"14563_CR12","doi-asserted-by":"crossref","unstructured":"Ozdemir BC, Gerard CL, Espinosa da Silva C. Sex and gender differences in anticancer treatment toxicity: a call for revisiting drug dosing in oncology. Endocrinology. 2022;163(6):bqac058.","DOI":"10.1210\/endocr\/bqac058"},{"issue":"11","key":"14563_CR13","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.medj.2022.08.005","volume":"3","author":"J Sponagel","year":"2022","unstructured":"Sponagel J, Jones JK, Frankfater C, Zhang S, Tung O, Cho K, Tinkum KL, Gass H, Nunez E, Spitz DR, et al. Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment. Med. 2022;3(11):792\u2013e811712.","journal-title":"Med"},{"key":"14563_CR14","doi-asserted-by":"publisher","first-page":"100152","DOI":"10.1016\/j.crphar.2022.100152","volume":"4","author":"HT Rakshith","year":"2023","unstructured":"Rakshith HT, Lohita S, Rebello AP, Goudanavar PS, Raghavendra Naveen N. Sex differences in drug effects and\/or toxicity in oncology. Curr Res Pharmacol Drug Discovery. 2023;4:100152.","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"14563_CR15","doi-asserted-by":"publisher","first-page":"175883592412729","DOI":"10.1177\/17588359241272970","volume":"16","author":"J Jeong","year":"2024","unstructured":"Jeong J, Park S, Heo KN, Park SM, Min S, Ah YM, Han JM, Lee JY. Comprehensive analysis of nationwide anticancer drug-related complications in korea: incidence, types, and cancer-specific considerations in contemporary oncology. Therapeutic Adv Med Oncol. 2024;16:17588359241272970.","journal-title":"Therapeutic Adv Med Oncol"},{"key":"14563_CR16","doi-asserted-by":"publisher","first-page":"836934","DOI":"10.3389\/fonc.2022.836934","volume":"12","author":"B Sieber","year":"2022","unstructured":"Sieber B, Strauss J, Li Z, Gatti-Mays ME. Concomitant medication effects on immune checkpoint inhibitor efficacy and toxicity. Front Oncol. 2022;12:836934.","journal-title":"Front Oncol"},{"issue":"11","key":"14563_CR17","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1093\/jnci\/djae163","volume":"116","author":"W Chen","year":"2024","unstructured":"Chen W, Altshuler RD, Daschner P, Salvador Morales C, St Germain DC, Guida J, Prasanna PGS, Buchsbaum JC. Older adults with cancer and common comorbidities-challenges and opportunities in improving their cancer treatment outcomes. J Natl Cancer Inst. 2024;116(11):1730\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"14563_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/life12010048","author":"D Basak","year":"2021","unstructured":"Basak D, Arrighi S, Darwiche Y, Deb S. Comparison of anticancer drug toxicities: paradigm shift in adverse effect profile. Life. 2021. https:\/\/doi.org\/10.3390\/life12010048.","journal-title":"Life"},{"issue":"3","key":"14563_CR19","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/S1470-2045(21)00639-2","volume":"23","author":"MI Printezi","year":"2022","unstructured":"Printezi MI, Kilgallen AB, Bond MJG, Stibler U, Putker M, Teske AJ, Cramer MJ, Punt CJA, Sluijter JPG, Huitema ADR, et al. Toxicity and efficacy of chronomodulated chemotherapy: a systematic review. Lancet Oncol. 2022;23(3):e129\u201343.","journal-title":"Lancet Oncol"},{"issue":"2","key":"14563_CR20","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1200\/OP.20.00517","volume":"17","author":"R Patell","year":"2021","unstructured":"Patell R, Einstein D, Miller E, Dodge L, Halleck J, Buss M. Patient perceptions of treatment benefit and toxicity in advanced cancer: A prospective Cross-Sectional study. JCO Oncol Pract. 2021;17(2):e119\u201329.","journal-title":"JCO Oncol Pract"},{"key":"14563_CR21","doi-asserted-by":"crossref","unstructured":"Paiva CE, Teixeira AC, Minto Lourenco B, Preto DD, Valentino TCO, Mingardi M, Paiva BSR. Anticancer treatment goals and prognostic misperceptions among advanced cancer outpatients. Int J Environ Res Public Health. 2022;19(10):6272.","DOI":"10.3390\/ijerph19106272"},{"issue":"3","key":"14563_CR22","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s00520-021-06663-2","volume":"30","author":"P Nizet","year":"2022","unstructured":"Nizet P, Touchefeu Y, Pecout S, Cauchin E, Beaudouin E, Mayol S, Fronteau C, Huon JF. Exploring the factors influencing adherence to oral anticancer drugs in patients with digestive cancer: a qualitative study. Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer. 2022;30(3):2591\u2013604.","journal-title":"Supportive Care Cancer: Official J Multinational Association Supportive Care Cancer"},{"issue":"2","key":"14563_CR23","doi-asserted-by":"publisher","first-page":"e0298928","DOI":"10.1371\/journal.pone.0298928","volume":"19","author":"JA Wiranata","year":"2024","unstructured":"Wiranata JA, Hutajulu SH, Astari YK, Leo B, Bintoro BS, Hardianti MS, Taroeno-Hariadi KW, Kurnianda J, Purwanto I. Patient-reported outcomes and symptom clusters pattern of chemotherapy-induced toxicity in patients with early breast cancer. PLoS One. 2024;19(2):e0298928.","journal-title":"PLoS One"},{"issue":"1","key":"14563_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1186\/s12885-019-6054-x","volume":"19","author":"KM Islam","year":"2019","unstructured":"Islam KM, Anggondowati T, Deviany PE, Ryan JE, Fetrick A, Bagenda D, Copur MS, Tolentino A, Vaziri I, McKean HA, et al. Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer. BMC Cancer. 2019;19(1):835.","journal-title":"BMC Cancer"},{"issue":"1","key":"14563_CR25","doi-asserted-by":"publisher","first-page":"e1451","DOI":"10.1002\/cnr2.1451","volume":"5","author":"F Horio","year":"2022","unstructured":"Horio F, Ikeda T, Arake Y, Kawashima N, Eto E, Matsukura M, Fujii I, Uchida Y. Consistency between patients and families in recognizing cancer chemotherapy side effects: a questionnaire survey. Cancer Rep (Hoboken). 2022;5(1):e1451.","journal-title":"Cancer Rep (Hoboken)"},{"issue":"4","key":"14563_CR26","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/cncr.20423","volume":"101","author":"M Hofman","year":"2004","unstructured":"Hofman M, Morrow GR, Roscoe JA, Hickok JT, Mustian KM, Moore DF, Wade JL, Fitch TR. Cancer patients\u2019 expectations of experiencing treatment-related side effects: a University of Rochester Cancer Center\u2013Community clinical oncology program study of 938 patients from community practices. Cancer. 2004;101(4):851\u20137.","journal-title":"Cancer"},{"issue":"1","key":"14563_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12885-018-4353-2","volume":"18","author":"SP Bauersfeld","year":"2018","unstructured":"Bauersfeld SP, Kessler CS, Wischnewsky M, Jaensch A, Steckhan N, Stange R, Kunz B, Br\u00fcckner B, Sehouli J, Michalsen A. The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer. 2018;18(1):476.","journal-title":"BMC Cancer"},{"issue":"1","key":"14563_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/2211738507666190122111224","volume":"7","author":"FA Fisusi","year":"2019","unstructured":"Fisusi FA, Akala EO. Drug combinations in breast cancer therapy. Pharm Nanotechnol. 2019;7(1):3\u201323.","journal-title":"Pharm Nanotechnol"},{"issue":"10","key":"14563_CR29","doi-asserted-by":"publisher","first-page":"476","DOI":"10.12968\/ijpn.2023.29.10.476","volume":"29","author":"AA Belmiro","year":"2023","unstructured":"Belmiro AA, Guilhem D. Quality of life assessment of patients undergoing palliative chemotherapy. Int J Palliat Nurs. 2023;29(10):476\u201385.","journal-title":"Int J Palliat Nurs"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14563-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14563-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T13:05:04Z","timestamp":1751807104000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14563-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14563"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14563-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,6]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with international and local ethical principles, including those outlined in the Declaration of Helsinki. Approval was obtained from the Institutional Review Board (IRB) of An-Najah National University (Approval reference number: Med. August. 2023\/21). Permission was also obtained from the Ministry of Health for the governmental hospitals. All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1149"}}